Literature DB >> 11207301

Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease.

A Wangoo1, T Sparer, I N Brown, V A Snewin, R Janssen, J Thole, H T Cook, R J Shaw, D B Young.   

Abstract

Mice that had received adoptive transfer of DO11.10 TCR transgenic T cells polarized toward a Th1 or a Th2 phenotype were challenged with Ag-coated beads or with recombinant Mycobacterium tuberculosis expressing the OVA determinant. The resulting bead-induced pulmonary granulomas reflected the phenotype of the adoptively transferred T cells, with the Th2 cells promoting a fibrotic reaction. Mice receiving Th1 cells mounted an epitope-specific protective response to challenge with recombinant M. tuberculosis. Th2 recipients were characterized by enhanced weight loss and lung fibrosis during acute high-dose infection. The combination of TCR transgenic T cells and epitope-tagged mycobacteria provides a novel experimental model for investigation of the pathogenesis of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207301     DOI: 10.4049/jimmunol.166.5.3432

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas.

Authors:  Manuela Flórido; Rui Appelberg
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 3.  The pathogenesis of systemic sclerosis revisited.

Authors:  Matthias Geyer; Ulf Müller-Ladner
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

4.  A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers.

Authors:  Daniel F Hoft; Azra Blazevic; Getahun Abate; Willem A Hanekom; Gilla Kaplan; Jorge H Soler; Frank Weichold; Larry Geiter; Jerald C Sadoff; Marcus A Horwitz
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

5.  Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection.

Authors:  Susana Lousada; Manuela Flórido; Rui Appelberg
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

Review 6.  Cytokines in the immunopathology of systemic sclerosis.

Authors:  Jasmin Raja; Christopher Paul Denton
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

7.  Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

Authors:  R A Fabre; T M Pérez; L D Aguilar; M J Rangel; I Estrada-Garcìa; R Hernández-Pando; S Estrada Parra
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

8.  Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model.

Authors:  J Dormans; M Burger; D Aguilar; R Hernandez-Pando; K Kremer; P Roholl; S M Arend; D van Soolingen
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.

Authors:  Helen A Fletcher; Patrick Owiafe; David Jeffries; Philip Hill; Graham A W Rook; Alimuddin Zumla; T Mark Doherty; Roger H Brookes
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

10.  Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes.

Authors:  Gina S García-Romo; Alexander Pedroza-González; Diana Aguilar-León; Hector Orozco-Estevez; Bart N Lambrecht; Iris Estrada-Garcia; Leopoldo Flores-Romo; Rogelio Hernández-Pando
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.